Zhejiang Orient Gene Biotech Stock

Detail Data
Volume (24h): 3,348,630 shares
P/E Ratio: /
Forward P/E: 0.85
EPS: -2.93 CNY
Forward EPS: 26.84 CNY
Number of Shares: 201,600,000 shares
Market Capitalization: 4,612,608,000.00 CNY

Dividend

Dividend Value
Dividend Amount According to our data, the company Zhejiang Orient Gene Biotech does not currently pay dividends.
Annual Yield %: -
Ex-dividend Date: 2023-06-26
5-Year Avg Yield %: -
Payout Ratio: -
Last Dividend Value: 2 CNY
Last Dividend Date: 2023-06-26

Analyst Forecast

Most analysts have issued a none recommendation for Zhejiang Orient Gene Biotech stock. The current number of analysts covering this company is No analyst coverage. The highest target price is / while the lowest target price is / The median target valuation set by analysts is / These forecasts and recommendations provide insight into how analysts view the future stock performance of Zhejiang Orient Gene Biotech.
Analysts Recommendation
Issued Recommendation: According to our data, the recommendation for Zhejiang Orient Gene Biotech stock is: none
Number of Analysts: Zhejiang Orient Gene Biotech is not covered by analysts.
Highest Target Price: /
Lowest Target Price: /
Median Target Price: /

Fundamental Indicators

Indicator Data
Total Revenue: 826,708,224.00 CNY
Net Income: -511,599,904.00 CNY
Price-to-Book (P/B): 0.64
PEG Ratio: /
Exchange: Shanghai
Industry: Medical Devices
Sector: Healthcare
Number of Employees:
Country: China

Where to Buy Zhejiang Orient Gene Biotech Stock?

You can purchase Zhejiang Orient Gene Biotech stock on the Shanghai under the ticker symbol: 688298.SS. Several stock brokers or banks offer trading services for these stocks. Popular stock brokers like XTB and eToro allow you to buy real stocks and ETFs with zero or minimal commissions. Banks usually charge higher fees. Remember, investing in stocks involves risks, so it's important to carefully consider your financial situation and investment goals.

1

Real stocks and ETFs. Low minimum deposit, only 50 EUR. Option to copy trades. Advanced stock analysis and free education.

Trustpilot rating 4.4/5 Google play rating 4.2/5
Invest in Stocks with eToro
★★★★★ 5.0
2

Real stocks and ETFs + free demo account. Low fees + fast customer support. More than 5,200 instruments available for trading. Free training and education. Regular live streams on YouTube.

Trustpilot rating 3.6/5 Google play rating 4.5/5
Try Free Demo Account
★★★★☆ 4.8
Risk warning: Trading CFDs involves a high risk of financial loss. Between 51%-eToro -89% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.

More Information on Zhejiang Orient Gene Biotech Stock

Indicator Value
Company Revenue: 826,708,224.00 CNY
EBITDA: -416,161,120.00 CNY - Negative EBITDA may signal financial challenges or growth investments.
Earnings Per Share: -2.93 CNY
Book Value Per Share: 35.61 CNY
Total Cash: 3,706,521,600.00 CNY
Total Cash per Share: 19.19 CNY
Total Debt: 564,096,128.00 CNY
Debt to Equity Ratio: 0.08
Quick Ratio -
Current Ratio -
Free Cash Flow -
Operating Cash Flow -
Gross Margins 100.00 %
EBITDA Margins -50.34 %
Operating Margins -98.87 %
Profit Margins -61.88 %
Return on Assets -
Return on Equity -7.0 %
Earnings Growth (1 year) -
Revenue Growth (1 year) 0.7 %
Quarterly Earnings Year-over-Year Growth -
Market Capitalization 4,612,608,000.00 CNY
Enterprise Value 2,032,205,824.00 CNY
EV/Revenue 2.458
EV/EBITDA -4.883
Float Shares 95,297,990 shares
Shares Outstanding 201,600,000 shares
Held Percent Insiders 0.50 %
Held Percent Institutions 6.80 %
Shares Short -
Shares Short Prior Month -
Date Short Interest -
Short Percentage of Total Shares -
Short Ratio -
Beta 1.68
Short Percentage of Float -
Implied Shares Outstanding 203,935,008

Frequently Asked Questions (FAQ)

According to our data, the company Zhejiang Orient Gene Biotech does not pay dividends yet, even in 2025.

Zhejiang Orient Gene Biotech shares are traded on the Shanghai stock exchange under the ticker: 688298.SS. You can buy or trade them through a variety of stock brokers who provide real stock trading services.

No prediction or recommendation from analysts has been issued for Zhejiang Orient Gene Biotech shares yet.

The total number of Zhejiang Orient Gene Biotech shares on the exchange is 201,600,000.00 shares, which at the current market capitalization gives the company a total valuation of 4,612,608,000.00 CNY.